Denosumab biosimilar by Lupin for Post Menopausal Osteoporosis: Likelihood of Approval

Denosumab biosimilar is under clinical development by Lupin and currently in Phase III for Post Menopausal Osteoporosis.

Low Testosterone Linked With Mortality Risk in Aging Men

A low serum testosterone level at baseline was associated with higher risk for all-cause and cardiovascular disease (CVD) mortality, a meta-analysis of 11 prospective cohort

May 14, 2024

AI-READI consortium launches groundbreaking diabetes data study

Researchers today (Nov. 8, 2024) are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of

November 8, 2024

Fujifilm invests $1.2bn ramping up North Carolina facility – Pharmaceutical Technology

Share this article The project is estimated to grow the state’s economy by $4.7bn over the next 12 years. Credit: Shutterstock / Robert Way Japanese

April 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.